Hualan Biological EngineeringInc (002007) — Cash Flow-to-Debt Ratio
Hualan Biological EngineeringInc (002007) has a Cash Flow-to-Debt Ratio of 0.11x as of September 2025, meaning its operating cash flow of CN¥319.46 Million could theoretically repay 0% of its total liabilities (CN¥3.02 Billion) in one year. See Hualan Biological EngineeringInc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hualan Biological EngineeringInc Cash Flow-to-Debt Ratio (2003–2024)
Historical debt coverage capacity for Hualan Biological EngineeringInc across 22 annual periods. For the full cash flow conversion analysis, see how efficiently does Hualan Biological EngineeringInc generate cash.
Annual Cash Flow-to-Debt Ratio for Hualan Biological EngineeringInc (2003–2024)
Year-by-year debt coverage analysis for Hualan Biological EngineeringInc. Check 002007 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.43x | CN¥1.06 Billion | CN¥2.46 Billion | ▼ -14.2% |
| 2023 | 0.50x | CN¥1.35 Billion | CN¥2.68 Billion | ▲ +32.5% |
| 2022 | 0.38x | CN¥957.31 Million | CN¥2.53 Billion | ▼ -34.7% |
| 2021 | 0.58x | CN¥1.43 Billion | CN¥2.47 Billion | ▼ -15.3% |
| 2020 | 0.68x | CN¥1.33 Billion | CN¥1.94 Billion | ▼ -64.9% |
| 2019 | 1.95x | CN¥1.36 Billion | CN¥699.26 Million | ▲ +8.6% |
| 2018 | 1.79x | CN¥1.29 Billion | CN¥720.47 Million | ▲ +281.5% |
| 2017 | 0.47x | CN¥177.42 Million | CN¥377.24 Million | ▼ -69.3% |
| 2016 | 1.53x | CN¥329.94 Million | CN¥215.05 Million | ▼ -61.7% |
| 2015 | 4.00x | CN¥548.62 Million | CN¥137.11 Million | ▲ +7.6% |
| 2014 | 3.72x | CN¥497.15 Million | CN¥133.70 Million | ▲ +142.1% |
| 2013 | 1.54x | CN¥510.70 Million | CN¥332.55 Million | ▼ -59.1% |
| 2012 | 3.75x | CN¥494.69 Million | CN¥131.84 Million | ▲ +72.0% |
| 2011 | 2.18x | CN¥335.93 Million | CN¥153.99 Million | ▼ -39.1% |
| 2010 | 3.58x | CN¥609.53 Million | CN¥170.06 Million | ▼ -8.2% |
| 2009 | 3.90x | CN¥607.73 Million | CN¥155.67 Million | ▲ +184.6% |
| 2008 | 1.37x | CN¥161.18 Million | CN¥117.50 Million | ▲ +121.1% |
| 2007 | 0.62x | CN¥179.02 Million | CN¥288.51 Million | ▲ +7.5% |
| 2006 | 0.58x | CN¥131.43 Million | CN¥227.67 Million | ▼ -12.3% |
| 2005 | 0.66x | CN¥98.24 Million | CN¥149.20 Million | ▲ +340.0% |
| 2004 | 0.15x | CN¥21.48 Million | CN¥143.53 Million | ▲ +878.5% |
| 2003 | 0.02x | CN¥3.35 Million | CN¥218.79 Million | — |